Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

1.88
BATS BZX Real-Time Price
As of 3:17pm ET
 +0.105 / +5.93%
Today’s Change
1.51
Today|||52-Week Range
14.10
-86.18%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close1.77
Today’s open1.78
Day’s range1.78 - 1.94
Volume46,280
Average volume (3 months)1,277,895
Market cap$154.5M
Dividend yield--
Data as of 3:17pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)-1.21%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QUREUniqure NV-0.26-4.34%
NVIVInVivo Therapeutics ...-0.08-1.52%
ENZYEnzymotec Ltd-0.10-1.57%
VBLTVascular Biogenics L...0.000.00%
Data as of 3:15pm ET, 12/02/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs